| Test Name: |
BRIVARACETAM, PLASMA |
| Test Code: |
2194149 |
| Alias: |
BRIVA
Briviact
LAB15315
|
| CPT Code(s): |
80299
|
| Preferred Specimen: |
1 mL EDTA plasma |
| Container: |
Lavender top tube (EDTA) |
| Alternate Container: |
Lavender top (K3 EDTA)
Green top (sodium or lithium heparin)
Light-blue top (sodium citrate) |
| Minimum Volume: |
0.5 mL plasma |
| Collection Instructions: |
1. Draw blood immediately before next scheduled dose.
2. For sustained-release formulations only, draw blood a minimum of 12 hours after last dose.
3. Within 2 hours of collection, centrifuge and aliquot plasma into a plastic vial.
|
| Transport Temperature: |
Refrigerated |
| Stability: |
Room Temperature: 28 days
Refrigerated: 28 days
Frozen: 28 days |
| Rejection Criteria: |
Serum; Plasma collected in a plasma gel tube |
| Limitations: |
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration. |
| Additional Information: |
This test cannot be performed on whole blood. |
| Schedule: |
Monday through Friday
Report Available: 1-3 days |
| Method: |
Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
|
| Performing Lab: |
Mayo Clinic Dept of Lab Med & Pathology #BRIVA |
| Clinical Significance: |
Useful for:
Assessing compliance and toxicity for brivaracetam |
| Use: |
Updated: 08/09/2024 |
| Reference Ranges: |
0.2-2.0 mcg/mL |
|
The CPT codes included in this publication are in accordance with Current Procedural Terminology, a publication of the American Medical Association. CPT codes are provided here for the convenience of our clients; however, correct coding often varies from one carrier to another, and HealthLab may bill specific carriers using codes other than those shown. Clients who bill for services should verify the code(s) with the applicable payor to confirm that their use is appropriate in each case.
|
| Test Type: |
|